Tag Archives: TB

President to launch TB Mukt Bharat initiative, target 2025

Posted on by
Reply

President Droupadi Murmu will virtually launch the TB Mukt Bharat Abhiyaan on Friday to reinvigorate the mission of TB elimination from the country by 2025.

Following the government’s initiative to end Tuberculosis or TB in the country five years ahead of Sustainable Development Goals (SDG) target of 2030 by the United Nations, the Abhiyaan will be launched in presence of Mansukh Mandaviya, Union Minister of Health and Family Welfare and other officials.

The virtual event will be attended by representatives from State and district health administration, corporates, industries, civil society and NGOs as the country reiterates the commitment towards TB elimination by 2025.

The TB Mukt Bharat Abhiyaan has been envisioned to bring together all community stakeholders to support those on TB treatment and accelerate the country’s progress towards TB elimination.

The President will also launch the Ni-kshay Mitra initiative which forms a vital component of the Abhiyaan. The Ni-kshay Mitra  portal provides a platform for donors to provide various forms of support to those undergoing TB treatment. The three pronged support includes nutritional, additional diagnostic, and vocational support.

The launch event aims to highlight the need for a societal approach that brings together people from all backgrounds to achieve the ambitious target of eliminating TB from the country by 2025, ahead of the SDG targets set by the UN.

SDG target to eliminate TB

Tuberculosis is an infectious bacterial disease caused by Mycobacterium tuberculosis, which most commonly affects the lungs. In June 2022, WHO’s Director-General Dr Tedros Adhanom Ghebreyesus held a dialogue with WHO’s Civil Society Task Force on Tuberculosis (CSTF-TB) sought to support the rapid adoption of WHO guidelines at country level.

It has called upon nations to increase access to the best evidence-based interventions for people and communities affected by TB, including prevention, detection and treatment of people with TB and related comorbidities, with the involvement of civil society and affected communities.

Clinical Trials of Antibiotics on Children

Posted on by
Reply

Central Licensing Authority i.e. Drugs Controller General (India) has given approval for conduct of various clinical trials of Antibiotics on children under one year of age. During the last three years, such clinical trials approved were mainly related to trials in Multi Drug Resistant Tuberculosis (MDRTB) and Tuberculosis Meningitis in children. The details of the clinical trials are registered in Clinical Trial Registry of India (CTRI), which is publicly available (www.ctri.nic.in).

Antibiotic use is a major driver of resistance. Neonates are more prone to infections and vulnerable to ineffective treatment. Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC).

Antibiotics are included in Schedule H and H1 to the Drugs & Cosmetics Rules, 1945, and, therefore, cannot be sold in retail except on and in accordance with the prescription of a Registered Medical Practitioner.

Indian Council of Medical Research (ICMR) has launched a programme on Antimicrobial Stewardship, Prevention of Infection and Control (ASPIC) in 2012. Functional infection control programmes not only cut down the rates of nosocomial infections, but also reduce the volume of antibiotic consumption and are a critical part of any comprehensive strategy to contain antimicrobial resistance (AMR). Further, a red line campaign has been launched to regulate over the counter sale of Schedule H antibiotics. The campaign is aimed at discouraging unnecessary prescription and over-the-counter sale of antibiotics causing drug resistance for several critical diseases including TB, malaria, urinary tract infection and even HIV.

The Ministry of Health & Family Welfare has also launched a programme named ‘National Programme on Containment of Antimicrobial Resistance’ to address the problem of growing AMR.

The Minister of State (Health and Family Welfare), Sh Faggan Singh Kulaste stated this in a written reply in the Rajya Sabha here today.